AstraZeneca
AZN
#47
Rank
HK$2.176 T
Marketcap
HK$702.00
Share price
0.17%
Change (1 day)
35.12%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: HK$2.176 Trillion

As of December 2025 AstraZeneca has a market cap of HK$2.176 Trillion. This makes AstraZeneca the world's 47th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$2.176 T36.46%
2024HK$1.594 T-2.18%
2023HK$1.630 T-0.81%
2022HK$1.643 T16.17%
2021HK$1.415 T39.35%
2020HK$1.015 T-0.37%
2019HK$1.019 T37.85%
2018HK$739.41 B8.62%
2017HK$680.71 B27.29%
2016HK$534.78 B-20.19%
2015HK$670.10 B-3.54%
2014HK$694.68 B20.9%
2013HK$574.61 B26.46%
2012HK$454.37 B-2.21%
2011HK$464.64 B-8.26%
2010HK$506.48 B-4.09%
2009HK$528.08 B15.07%
2008HK$458.93 B-5.65%
2007HK$486.44 B-23.76%
2006HK$638.02 B5.43%
2005HK$605.16 B30.17%
2004HK$464.91 B-26.77%
2003HK$634.88 B34.99%
2002HK$470.31 B-25.84%
2001HK$634.19 B-10.59%
2000HK$709.33 B23.14%
1999HK$576.03 B74.43%
1998HK$330.24 B24.73%
1997HK$264.77 B29.07%
1996HK$205.14 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of AstraZeneca was reported to be:

HK$2.177 Trillion
by Nasdaq info icon info icon
HK$2.176 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Bristol-Myers Squibb
BMY
HK$826.42 B-62.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.152 T-47.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.938 T-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$760.68 B-65.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
HK$941.12 B-56.76%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
HK$7.050 T 223.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.787 T 74.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.694 T-22.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$207.04 B-90.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$1.974 T-9.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland